Betta will reasonably cooperate with [[Agenus:Organization]] to enable [[Agenus:Organization]] to ascertain that all uses of all of the Product Marks, as permitted hereunder, meet the quality standards set by [[Agenus:Organization]] in connection with its existing uses of each of such Product Mark, including by allowing [[Agenus:Organization]] and its representatives to make periodic inspection of Betta’s packaging, inserts, records, documents and other materials that contain any such Product Mark.

Product Trademarks. All Products shall be sold under one or more Trademarks selected and owned by Coya or its Affiliates or Sublicensees in the Territory. As between the Parties, Coya shall control the preparation, prosecution and maintenance of applications related to all such Trademarks in the Territory, at its sole cost and expense and at its sole discretion. ARScience Bio shall notify Coya promptly upon learning of any actual, alleged or threatened infringement of a Trademark applicable to a Product in the Territory, or of any unfair trade practices, trade dress imitation, passing off of counterfeit goods, or like offenses in the Territory. As between the Parties, all of the costs, expenses and legal fees in bringing, maintaining and prosecuting any action to maintain, protect or defend any Trademark owned by Coya or its Affiliate or Sublicensee hereunder, and any damages or other recovery, shall be Coya’s sole responsibility, and taken in its sole discretion.

Product Reversion. Upon termination of this Agreement by Licensee pursuant to Section

means any pharmaceutical product for injection or infiltration or similar manner of administration # comprising the Active Ingredient as the sole active pharmaceutical ingredient and # comprising ​, including the product described on [Exhibit 1.24] (the “Initial Product”) and any Reformulations thereof. For clarity, Licensed Product shall exclude any product Controlled by INNOCOLL as of the Effective Date and any modification, revision, reformulation or improvement to any such product made after the Effective Date, so long as such modification, revision, reformulation or improvement does not use or incorporate ​.

Work Product. Executive acknowledges that all ideas, inventions, innovations, improvements, developments, methods, designs, analyses, reports, databases, and any other similar or related information (whether patentable or not) which relate to the actual or anticipated business, research and development, or existing or known future products or services of the Company which are or were conceived, developed or created by Executive (alone or jointly with others) during Executive’s Company Employment (the “Work Product”) is and shall remain the exclusive property of the Company. Executive acknowledges and agrees that all copyrightable Work Product was created in Executive’s capacity as an employee of [[Company:Organization]] and within the scope of Executive’s Company Employment, and thus constitutes a “work made for hire” under the Copyright Act of 1976, as amended. Executive hereby assigns to the Company all right, title and interest in and to all Work Product, and agrees to perform all actions reasonably requested by the Company to establish, confirm or protect the Company’s ownership thereof (including, without limitation, executing assignments, powers of attorney and other instruments).

If Licensee or its Affiliates or Sublicensees sell a Licensed Product in a Combination Product, then the Sales for such Licensed Product shall be calculated by ​.

Based on the sales results and sales strategy, Bitmain is willing to offer the following discount as set forth in clause 4.1:

The estimated delivery schedule, reference quantity, total rated hashrate, unit price and total price are as follows:

Work Product. Notwithstanding that Sunovion will be the Disclosing Party with respect to the Work Product, # the Work Product shall be deemed to be the Confidential Information of Urovant, and # Urovant shall be deemed to be the “Disclosing Party” and Sunovion shall be deemed to be the “Receiving Party” with respect thereto.

Work Product. Urovant shall own all # the Materials that are generated by the Parties (either solely or jointly) under this Agreement; # data, analyses, reports and other work product solely related to the Product generated by Sunovion under this Agreement (“Work Product”); and # all inventions (whether patentable or not), improvements, developments and intellectual property rights related thereto (including any patent applications, patents, copyrights, trademarks and goodwill), that in each case are conceived, reduced to practice, made or authored by Sunovion (whether solely or jointly) under this Agreement and solely relate to the Product (collectively, “IP”). Sunovion shall disclose all Work Product and IP to Urovant in writing promptly after such Work Product is completed or created.